Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 5, 2001, Pages 1256-1276

  Pauwels, R A ^a   Buist, A S ^a   Calverley, P M A ^a   Jenkins, C R ^a   Hurd, S S ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 0035035768     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.5.2101039     Document Type: Conference Paper

References (210)

1. Evidence-based health policy - Lessons from the Global Burden of Disease Study
2. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis
3. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
4. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease
5. Airway inflammation in COPD assessed by sputum levels of interleukin-8
6. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis
7. Reassessment of inflammation of airways in chronic bronchitis
8. The relations between structural changes in small airways and pulmonary-function tests
9. Pathologic changes in the peripheral airways of young cigarette smokers
10. Morphology of peripheral airways in current smokers and ex-smokers
11. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation
12. Cigarette smoking and lung destruction: Accumulation of neutrophils in the lungs of cigarette smokers
13. Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats
14. Cytotoxicity and induction of proinflammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor and indoor air
15. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers
16. Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge
17. Mechanisms of neutrophil recruitment to the lung by grain dust exposure
18. 1
19. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis
20. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease
21. Centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis
22. Pathogenesis of pulmonary emphysema
23. Oxidative stress in chronic obstructive pulmonary disease
24. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease: The effect of oxygen and exercise
25. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
26. Vascular remodeling
27. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part Two
28. Diagnostic labels applied to model case histories of chronic airflow obstruction: Responses to a questionnaire in 11 North American and western European countries
29. Obstructive lung disease deaths in the United States from 1979 through 1993: An analysis using multiple-cause mortality data
30. Smoking and other risk factors
31. International comparisons in COPD mortality
32. 1: New insight into gender differences
33. Trends in COPD morbidity and mortality in the United States
34. 1. The Lung Health Study
35. The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency
36. Antiproteases
37. Inherited susceptibility of the lung to proteolytic injury
38. The host factor in bronchitis
39. Asthma in adult life - Is there an association with birth weight?
40. Birth characteristics and asthma symptoms in young adults: Results from a population-based cohort study in Norway
41. Mild prematurity and respiratory functions
42. Relation of fetal growth to adult lung function in South India
43. Maternal smoking and infant lung function: Further evidence for an in utero effect
44. The natural history of forced expiratory volumes: Effect of cigarette smoking and respiratory symptoms
45. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study)
46. Passive smoking in obstructive respiratory disease in an industrialized urban population
47. Immune and inflammatory function in cigarette smokers
48. Twelve years spirometric changes among Paris area workers
49. Anatomic and pathophysiological correlations in COPD
50. Worldwide epidemiology of chronic obstructive pulmonary disease
51. Exposure to biomass smoke and chronic airway disease in Mexican women
52. Risk factors for chronic obstructive lung disease in Saudi Arabia
53. Respiratory symptoms in Indian women using domestic cooking fuels
54. Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke
55. Wood-smoke exposure and risk for obstructive airways disease among women
56. Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal
57. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal
58. Health effects and sources of indoor air pollution
59. Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai
60. Socioeconomic status, lung function and admission to hospital for COPD: Results from the Copenhagen City Heart Study
61. Epidemiology: A British perspective
62. Symptoms and signs of COPD
63. Alteration in breathing pattern with progression of chronic obstructive pulmonary disease
64. Physician perceptions and management of COPD
65. Response to bronchodilators
66. Lung function testing: Selection of reference values and interpretative strategies
67. "Sick of Smoking": Evaluation of a targeted minimal smoking cessation intervention in general practice
68. Helping people to stop smoking: The new smoking cessation guidelines
69. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. A clinical practice guideline for treating tobacco use and dependence
70. Physician-initiated smoking cessation program: The National Cancer Institute trials
71. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis
72. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library
73. BTS guidelines for the management of chronic obstructive pulmonary disease
74. Ambient air pollution
75. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease
76. Can a pulmonary health teaching program alter patients' ability to cope with COPD?
77. Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease
78. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: Short-term effects on exercise endurance and health status
79. Pulmonary rehabilitation in patients with COPD
80. Outcomes of advance directive education of pulmonary rehabilitation patients
81. Effective physician-patient communication and health outcomes: A review
82. Physician-patient partnership in managing chronic illness
83. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
84. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
85. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
86. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
87. High-dose inhaled albuterol in severe chronic airflow limitation
88. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease: A three-center study
89. Dose response relation to oral theophylline in severe chronic obstructive airways disease
90. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis
91. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation
92. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease
93. Bronchodilators in chronic air-flow limitation: Effects on airway function, exercise capacity, and quality of life
94. Quality of life changes in COPD patients treated with salmeterol
95. Efficacy of salmeterol xinafoate in the treatment of COPD
96. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial
97. Routine nebulized ipratropium and albuterol together are better than either alone in COPD
98. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease
99. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: A single centre randomised, double blind, placebo controlled, crossover study
100. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction
101. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium
102. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease
103. A long-term prospective assessment of home nebulizer treatment
104. Results of a multicenter study of nebulized inhalant bronchodilator solutions
105. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease
106. Withdrawal of chronic systemic corticosteroids in patients with COPD: A randomized trial
107. Corticosteroids contribute to muscle weakness in chronic airflow obstruction
108. Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma
109. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
110. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease
111. Efficacy of pneumococcal vaccine in high-risk patients: Results of a Veterans Administration Cooperative Study
112. Pneumococcal vaccine and patients with chronic lung disease
113. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease: A pilot study
114. Chronic bronchitis: The role of antibiotics
115. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
116. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
117. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
118. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis
119. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction
120. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases
121. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis
122. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
123. OM-8BV for COPD
124. Managing cough as a defense mechanism and as a symptom: A consensus panel report of the American College of Chest Physicians
125. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
126. NO: COPD and beyond
127. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease
128. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease
129. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease
130. Oral diamorphine: Lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome
131. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease
132. Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction
133. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases
134. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease
135. Exercise rehabilitation and chronic obstructive pulmonary disease stage
136. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction
137. Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme
138. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial
139. Randomised controlled trial of respiratory rehabilitation
140. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home
141. Physical rehabilitation for the chronic bronchitic: Results of a controlled trial of exercises in the home
142. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial
143. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema
144. Long-term oxygen therapy
145. Indications for surgery and patient work-up for bullectomy
146. Surgical options for patients with advanced emphysema
147. Effect of lung-volume-reduction surgery in patients with severe emphysema
148. Rationale and design of The National Emphysema Treatment Trial: A prospective randomized trial of lung volume reduction surgery
149. Lung transplantation
150. Lung transplantation comes of age
151. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official report - 1998
152. International guidelines for the selection of lung transplant candidates
153. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: Resource intensity, hospital costs, and survival
154. Severe exacerbation of chronic obstructive airways disease: Health resource use in general practice and hospital
155. Respiratory failure revisited: Acute exacerbations of chronic bronchitis between 1961-68 and 1970-76
156. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
157. The role of infection in COPD
158. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
159. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases
160. Prospective study of aetiology and outcome of adult lower-respiratory tract infections in the community
161. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD
162. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project
163. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis
164. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease
165. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection
166. Simultaneous respiratory tract colonization by multiple strains of nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease: Implications for antibiotic therapy
167. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD
168. 1 in acute exacerbation of COPD
169. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease
170. Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease
171. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation
172. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
173. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
174. Outcomes following acute exacerbation of severe chronic obstructive lung disease
175. Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: Cost minimisation analysis
176. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service
177. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease
178. Comparison of one versus two bronchodilators in ventilated COPD patients
179. Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease
180. Theophylline for irreversible chronic airflow limitation: A randomized study comparing n of 1 trials to standard practice
181. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease
182. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease
183. Theophylline concentrations in patients with acute exacerbation of COPD
184. Noninvasive positive pressure ventilation to treat respiratory failure
185. International Consensus Conferences in Intensive Care Medicine: Noninvasive positive pressure ventilation in acute respiratory failure
186. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
187. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
188. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
189. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: A multicentre randomised controlled trial
190. How is mechanical ventilation employed in the intensive care unit? An international utilization review
191. A comparison of four methods of weaning patients from mechanical ventilation
192. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation
193. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: A randomized, controlled trial
194. Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency
195. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease
196. The necessary length of hospital stay for chronic pulmonary disease
197. Inpatient management of chronic obstructive pulmonary disease
198. Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis
199. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands
200. The economic impact of asthma and COPD in Sweden 1980 and 1991